|
2018-12-26 |
2018-12-24 |
V
Vente
|
Gurney Austin
See Remarks
Dirigeant
|
11 117
-14.3%
0,60
6 669 USD
|
11 117
-14.3%
|
0,60
|
6 669 USD
|
|
|
2018-10-11 |
2018-10-10 |
V
Vente
|
Li Yvonne
See Remarks
Dirigeant
|
927
-1.5%
2,02
1 873 USD
|
927
-1.5%
|
2,02
|
1 873 USD
|
|
|
2018-10-11 |
2018-10-10 |
V
Vente
|
Stagg Robert
SVP, Clinical R&D
Dirigeant
|
927
-2.2%
2,01
1 863 USD
|
927
-2.2%
|
2,01
|
1 863 USD
|
|
|
2018-10-11 |
2018-10-10 |
V
Vente
|
Lewicki John A.
President & CEO
Administrateur exécutif
|
1 156
-2.0%
2,01
2 324 USD
|
1 156
-2.0%
|
2,01
|
2 324 USD
|
|
|
2018-10-11 |
2018-10-10 |
V
Vente
|
Hager Alicia J.
SVP & General Counsel
Dirigeant
|
1 156
-2.2%
2,02
2 335 USD
|
1 156
-2.2%
|
2,02
|
2 335 USD
|
|
|
2018-10-11 |
2018-10-10 |
V
Vente
|
Gurney Austin
See Remarks
Dirigeant
|
1 156
-1.5%
2,01
2 324 USD
|
1 156
-1.5%
|
2,01
|
2 324 USD
|
|
|
2018-10-10 |
2018-10-09 |
V
Vente
|
Stagg Robert
SVP, Clinical R&D
Dirigeant
|
1 686
-3.9%
2,13
3 589 USD
|
1 686
-3.9%
|
2,13
|
3 589 USD
|
|
|
2018-10-10 |
2018-10-09 |
VP
Vente planifiée
|
Li Yvonne
See Remarks
Dirigeant
|
1 229
-2.0%
2,13
2 616 USD
|
1 229
-2.0%
|
2,13
|
2 616 USD
|
|
|
2018-10-10 |
2018-10-09 |
VP
Vente planifiée
|
Gurney Austin
See Remarks
Dirigeant
|
1 686
-2.1%
2,13
3 589 USD
|
1 686
-2.1%
|
2,13
|
3 589 USD
|
|
|
2018-10-10 |
2018-10-09 |
VP
Vente planifiée
|
Lewicki John A.
President & CEO
Administrateur exécutif
|
2 296
-3.9%
2,13
4 888 USD
|
2 296
-3.9%
|
2,13
|
4 888 USD
|
|
|
2018-10-10 |
2018-10-09 |
V
Vente
|
Hager Alicia J.
SVP & General Counsel
Dirigeant
|
1 686
-3.1%
2,13
3 589 USD
|
1 686
-3.1%
|
2,13
|
3 589 USD
|
|
|
2018-04-26 |
2018-04-24 |
V
Vente
|
Stagg Robert
SVP, Clinical R&D
|
4 051
-8.6%
2,68
10 848 USD
|
4 051
-8.6%
|
2,68
|
10 848 USD
|
|
|
2018-04-26 |
2018-04-24 |
V
Vente
|
Lewicki John A.
President & CEO
Administrateur exécutif
|
4 557
-7.6%
2,68
12 202 USD
|
4 557
-7.6%
|
2,68
|
12 202 USD
|
|
|
2018-04-26 |
2018-04-24 |
V
Vente
|
Gurney Austin
See Remarks
|
4 051
-5.0%
2,68
10 848 USD
|
4 051
-5.0%
|
2,68
|
10 848 USD
|
|
|
2018-04-26 |
2018-04-24 |
V
Vente
|
Li Yvonne
See Remarks
|
5 062
-7.8%
2,68
13 555 USD
|
5 062
-7.8%
|
2,68
|
13 555 USD
|
|
|
2018-04-26 |
2018-04-24 |
V
Vente
|
Hager Alicia J.
SVP & General Counsel
|
4 051
-6.9%
2,68
10 848 USD
|
4 051
-6.9%
|
2,68
|
10 848 USD
|
|
|
2017-10-12 |
2017-10-10 |
V
Vente
|
Hager Alicia J.
SVP & General Counsel
|
1 202
-2.0%
4,24
5 099 USD
|
1 202
-2.0%
|
4,24
|
5 099 USD
|
|
|
2017-10-12 |
2017-10-10 |
V
Vente
|
Hager Alicia J.
SVP & General Counsel
|
46
-0.1%
4,26
196 USD
|
46
-0.1%
|
4,26
|
196 USD
|
|
|
2017-10-12 |
2017-10-10 |
V
Vente
|
Patel Sunil
See Remarks
|
1 202
-1.7%
4,24
5 099 USD
|
1 202
-1.7%
|
4,24
|
5 099 USD
|
|
|
2017-10-12 |
2017-10-10 |
V
Vente
|
Patel Sunil
See Remarks
|
46
-0.1%
4,27
196 USD
|
46
-0.1%
|
4,27
|
196 USD
|
|
